New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302
b'Credits: 0.25 AMA PRA Category 1 Credit\\u2122\\xa0\\n\\xa0\\nCME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302\\n\\xa0\\nOverview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.\\n\\xa0\\nEpisode resource links:\\nAACE Guideline:\\xa0 Endocrine Pract: May 2022, 28(5): 528-562\\nCoffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596\\n\\xa0\\nGuest: Robert A. Baldor, MD\\n\\xa0\\nMusic Credit: Richard Onorato'